Enzychem Lifesciences announces the FDA Orphan Drug Designation granted to EC-18 on Acute Radiation Syndrome (ARS)

January 19, 2018

Responsive image

FORT LEE, N.J., Jan. 19, 2018 /PRNewswire/ — Enzychem Lifesciences, Corp. (KONEX:183490), announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to EC-18 for the treatment of Acute Radiation Syndrome (ARS).
The US FDA Orphan Drug Designation progr…

Category: Precious Metals